-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
There are many people all over the world suffering from what is calledUlcerative colitis , a chronic inflammatory bowel disease characterized by erosions and ulcers in the colonic mucosa,Ulcerative colitis is involved in the development of chronic and aggressive inflammation, yet researchers have not completely eliminated its specific pathogenes.
There are many people all over the world suffering from what is calledUlcerative colitis , a chronic inflammatory bowel disease characterized by erosions and ulcers in the colonic mucosa,Ulcerative colitis is involved in the development of chronic and aggressive inflammation, yet researchers have not completely eliminated its specific pathogenes.
Recently, in a research report titled "A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent" published in the international journal Scientific Reports , scientists from Osaka University and other institutions passedThe study designed an absorbable formulation that may target the high-level oxidative mechanisms associated with ulcerative colitis in laboratory mouse mode.
Previous studies have shown that there are high levels of reactive oxygen radicals (ROS) in the intestinal mucosa of patients with ulcerative colit.
Hydrogen produced by silicon-based absorbable formulations may reduce inflammation levels in patients with ulcerative colit.
Hydrogen produced by silicon-based absorbable formulations may reduce inflammation levels in patients with ulcerative colit.
Image source: Scientific Reports , Yoshihisa Koyama et al, Scientific Reports
In fact, studies have reported that hydrogen is a strong antioxidant that can show promising results in a variety of diseases, including inflammatory bowel disea.
In fact, studies have reported that hydrogen is a strong antioxidant that can show promising results in a variety of diseases, including inflammatory bowel disea.
Mice given the therapeutic formulation had decreased levels of specific proinflammatory cytokines, and the silicon-based formulation significantly reduced colonic atrophy, bleeding, and damage associated with chronic inflammati.
Taken together, our findings reveal that silicon-based absorbable formulations may hold promise as a novel therapy for human inflammatory bowel disea.
Original source:
Koyama,.
Koyama,.
, Kobayashi,.
, Hirota,.
et .
A new therapy against ulcerative colitis via the intestine and brain using the Si-based agen.
Sci Rep12, 9634 (202
doi: 11038/s41598- 022-13655-7 et .
A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent Sci Rep Leave a comment here
